Simulation to optimize the laboratory diagnosis of bacteremia.

blood culture bloodstream infections clinical microbiology discrete event simulation

Journal

Microbiology spectrum
ISSN: 2165-0497
Titre abrégé: Microbiol Spectr
Pays: United States
ID NLM: 101634614

Informations de publication

Date de publication:
24 Sep 2024
Historique:
medline: 24 9 2024
pubmed: 24 9 2024
entrez: 24 9 2024
Statut: aheadofprint

Résumé

Blood cultures are central to the management of patients with sepsis and bloodstream infection. Clinical decisions depend on the timely availability of laboratory information, which, in turn, depends on the optimal laboratory processing of specimens. Discrete event simulation (DES) offers insights into where optimization efforts can be targeted. Here, we generate a detailed process map of blood culture processing within a laboratory and use it to build a simulator. Direct observation of laboratory staff processing blood cultures was used to generate a flowchart of the blood culture laboratory pathway. Retrospective routinely collected data were combined with direct observations to generate probability distributions over the time taken for each event. These data were used to inform the DES model. A sensitivity analysis explored the impact of staff availability on turnaround times. A flowchart of the blood culture pathway was constructed, spanning labeling, incubation, organism identification, and antimicrobial susceptibility testing. Thirteen processes in earlier stages of the pathway, not otherwise captured by routinely collected data, were timed using direct observations. Observations revealed that specimen processing is predominantly batched. Another eight processes were timed using retrospective data. A simulator was built using DES. Sensitivity analysis revealed that specimen progression through the simulation was especially sensitive to laboratory technician availability. Gram stain reporting time was also sensitive to laboratory scientist availability. Our laboratory simulation model has wide-ranging applications for the optimization of laboratory processes and effective implementation of the changes required for faster and more accurate results. Optimization of laboratory pathways and resource availability has a direct impact on the clinical management of patients with bloodstream infection. This research offers an insight into the laboratory processing of blood cultures at a system level and allows clinical microbiology laboratories to explore the impact of changes to processes and resources.

Identifiants

pubmed: 39315787
doi: 10.1128/spectrum.01449-24
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0144924

Auteurs

Alessandro Gerada (A)

Antimicrobial Pharmacodynamics and Therapeutics Group, Pharmacology Department, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Department of Infection and Immunity, Liverpool Clinical Laboratories, Clinical Support Services Building (CSSB), Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Gareth Roberts (G)

Antimicrobial Pharmacodynamics and Therapeutics Group, Pharmacology Department, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Department of Infection and Immunity, Liverpool Clinical Laboratories, Clinical Support Services Building (CSSB), Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Alex Howard (A)

Antimicrobial Pharmacodynamics and Therapeutics Group, Pharmacology Department, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Department of Infection and Immunity, Liverpool Clinical Laboratories, Clinical Support Services Building (CSSB), Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Nada Reza (N)

Antimicrobial Pharmacodynamics and Therapeutics Group, Pharmacology Department, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, United Kingdom.

Anoop Velluva (A)

Antimicrobial Pharmacodynamics and Therapeutics Group, Pharmacology Department, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, United Kingdom.

Conor Rosato (C)

Antimicrobial Pharmacodynamics and Therapeutics Group, Pharmacology Department, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, United Kingdom.

Peter L Green (PL)

Antimicrobial Pharmacodynamics and Therapeutics Group, Pharmacology Department, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
School of Engineering, Foundation Building, University of Liverpool, Liverpool, United Kingdom.

William Hope (W)

Antimicrobial Pharmacodynamics and Therapeutics Group, Pharmacology Department, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
Department of Infection and Immunity, Liverpool Clinical Laboratories, Clinical Support Services Building (CSSB), Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.

Classifications MeSH